Submission of Pen device in an ANDA 505(j)

P

parmohan

#1
hi,
We manufacture finished products and want to submit an ANDA containing pen developed outside. The vendor is not having a 510(K) submission and we would like to submit the pen in our ANDA. can we do that?

If Yes, which information will be required for the submission and in which section.
 
Elsmar Forum Sponsor

Ronen E

Problem Solver
Moderator
#2
What types of marketing applications are required for a combination product?

Combination products are typically marketed under a marketing authorization type associated with the constituent part that provides the primary mode of action (PMOA) for the combination product (i.e., a new drug application (NDA) or abbreviated new drug application (ANDA) if it has a drug PMOA, a biologic license application (BLA) if it has a biologic PMOA, or a premarket approval application (PMA) de novo certification, or premarket notification (“510(k)”) if it has a device PMOA). A single marketing application is generally sufficient for a combination product. In some cases, however, a sponsor may wish to submit separate marketing applications for different constituent parts of a combination product, and FDA may consider this permissible.
How are combination products assigned for review?

Combination products are assigned to a FDA center that will have primary jurisdiction for its premarket review and regulation. Consistent with section 503(g)(1) of the Act, assignment to a center with primary jurisdiction for premarket review and post-market regulation, or a lead center, is based on a determination of the “primary mode of action” (PMOA) of the combination product. For example, if the PMOA of a device-biological combination product is attributable to the biological product, the Agency component responsible for premarket review of that biological product would have primary jurisdiction for the combination product.

Section 503(g) defines primary mode of action as “the single mode of action of a combination product that provides the most important therapeutic action of the combination product” (see also definitions at 21 CFR 3.2. In some cases, the most important therapeutic action cannot be determined. For example, a combination product may have two independent modes of action, neither of which is subordinate to the other. To resolve these types of questions, FDA’s regulations at 21 CFR Part 3 include an algorithm for determining center assignment. The algorithm directs center assignment based on which center regulates combination products raising similar types of safety and effectiveness questions, or, if there is no such center, based on which center has the most expertise to evaluate the most significant safety and effectiveness questions raised by the combination product.
The above are from: Frequently Asked Questions About Combination Products

Everything you need on combination products: Combination Products
 
Thread starter Similar threads Forum Replies Date
A A strange question about predicate device selected in 510(k) submission Medical Device and FDA Regulations and Standards News 8
V FDA 510K - Pre Submission Query US Food and Drug Administration (FDA) 6
K Level 1 PPAP Submission APQP and PPAP 11
R Withdraw IMDS submission RoHS, REACH, ELV, IMDS and Restricted Substances 3
G Similarities between format of technical file for CE and ASEAN common submission dossier template (CSDT) CE Marking (Conformité Européene) / CB Scheme 2
L Notified Body submission - Pre-filled syringes EU Medical Device Regulations 2
B Document Retention period for MHRA submission UK Medical Device Regulations 0
M ESTAR 510(k) submission question Medical Device and FDA Regulations and Standards News 0
S Discussion on OBL and OEM test data for submission as per new EUMDR EU Medical Device Regulations 0
V Recommended EU 2017/745 electronic submission format EU Medical Device Regulations 3
L How to find a good 510(k) submission training? Other US Medical Device Regulations 2
L How to find a good online CFDA submission training? China Medical Device Regulations 5
H Do you repeat information throughout your documentation submission? EU Medical Device Regulations 4
S FDA 510(K) submission question US Food and Drug Administration (FDA) 4
B Client lost copy of previous 513(g) submission package and responses US Food and Drug Administration (FDA) 1
J 3P510K submission US Food and Drug Administration (FDA) 2
T Accessories and Parent Device Submission Medical Device and FDA Regulations and Standards News 1
D New license submission - Correct Email Canada Medical Device Regulations 1
B How to submit Pre-submission to FDA? US Food and Drug Administration (FDA) 4
V 510 k submission RTA (Acceptance Checklist ) Other US Medical Device Regulations 8
T IMDS submission without supplier's input? RoHS, REACH, ELV, IMDS and Restricted Substances 5
J Part submission warrant for Level 1 PPAP APQP and PPAP 1
N Traditional 510K Submission-Financial Certification or Disclosure Statement 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
S Transitional Adolescent A and B - "CDRH PREMARKET REVIEW SUBMISSION COVER SHEET FORM FDA 3514" Medical Device and FDA Regulations and Standards News 1
B Health Canada Submission Canada Medical Device Regulations 2
S PSUR - MDR First Submission Requirement? EU Medical Device Regulations 8
S Pre-Submission for Breakthrough Device Designation - What's the threshold? US Food and Drug Administration (FDA) 8
P Writing a presubmission to the FDA prior to the De novo submission US Food and Drug Administration (FDA) 4
A Which guidance do you use for guiding the requirements of IFU for 510(k) submission? Medical Device and FDA Regulations and Standards News 5
D Amendment Class II - Please confirm if the submission is by email (Canada) - Help Canada Medical Device Regulations 0
T 510(k) submission - Which name should I use in the submission? Other US Medical Device Regulations 3
G Gage R&R - Where am I going wrong? Part of a FAIR submission (Aerospace) Gage R&R (GR&R) and MSA (Measurement Systems Analysis) 2
K Submission of MDR File - Partner Companies - Computed Tomography (CT) CE Marking (Conformité Européene) / CB Scheme 10
A Some questions about voluntary consensus standards in traditional 510(k) submission US Food and Drug Administration (FDA) 6
A Some doubts about traditional 510(k) submission US Food and Drug Administration (FDA) 5
A Bench test report translation to English for 510(k) submission Other US Medical Device Regulations 2
S PMS (Premarket Submission) and PMCF Plan EU Medical Device Regulations 5
T First 510(k) submission - Class II software as medical device US Food and Drug Administration (FDA) 3
J IMDS submission details for aluminium wrought alloys APQP and PPAP 5
K 510(K) File eCopy Submission 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 16
S Two or more predicates suitable? 510K submission US Food and Drug Administration (FDA) 5
P Predicate Device Information for 510(k) Submission Medical Device and FDA Regulations and Standards News 4
M Timing of 510k submission Other US Medical Device Regulations 9
Ronen E Can anyone please explain this? (510k submission requirement) Other US Medical Device Regulations 14
D First 510(k) Submission - Don't Forget Tips US Food and Drug Administration (FDA) 5
P 21 CFR 807.81 When a premarket notification submission is required Other US Medical Device Regulations 0
J China NMPA medical device submission timelines and clearance rates China Medical Device Regulations 2
D Is Human Factors testing mandatory for a 510(k) submission? Human Factors and Ergonomics in Engineering 16
D Pre-Submission after 510(K) Submission? Other US Medical Device Regulations 4
M CBE (Change Being Effected) 510(k) Submission Other US Medical Device Regulations 2

Similar threads

Top Bottom